Midpregnancy levels of angiogenic markers in relation to maternal characteristics
- 31 March 2011
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 204 (3) , 244.e1-244.e12
- https://doi.org/10.1016/j.ajog.2010.10.001
Abstract
No abstract availableKeywords
Funding Information
- Diabetes UK (RD 05-0003099)
- National Institute of Child Health and Human Development
- March of Dimes Foundation (20-FY04-37, 20FY01-38)
- Thrasher Research Fund (02816-7)
- National Institutes of Health
- Michigan State University (5K12HD001255)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute of Nursing Research (R01 HD34543)
- Centers for Disease Control and Prevention (T32 HD046377, U01 DP000143-01)
This publication has 52 references indexed in Scilit:
- Levels of maternal serum corticotropin-releasing hormone (CRH) at midpregnancy in relation to maternal characteristicsPsychoneuroendocrinology, 2010
- How Does Smoking Reduce the Risk of Preeclampsia?Hypertension, 2010
- Circulating angiogenic factors in gestational proteinuria without hypertensionAmerican Journal of Obstetrics and Gynecology, 2009
- Midpregnancy Vaginal Fluid Defensins, Bacterial Vaginosis, and Risk of Preterm DeliveryObstetrics & Gynecology, 2008
- Circulating soluble endoglin and placental abruptionPrenatal Diagnosis, 2008
- Cigarette Smoke Exposure and Angiogenic Factors in Pregnancy and PreeclampsiaAmerican Journal of Hypertension, 2008
- Interactions between Smoking and Weight in Pregnancies Complicated by Preeclampsia and Small-for-Gestational-Age BirthAmerican Journal of Epidemiology, 2008
- Circulating and Placental Endoglin Concentrations in Pregnancies Complicated by Intrauterine Growth Restriction and PreeclampsiaPlacenta, 2008
- The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational ageThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonateThe Journal of Maternal-Fetal & Neonatal Medicine, 2008